IP Library Granted Patent US 11,911,503
Granted Patent B2
US 11,911,503 · App. 17/225,634 · Granted Feb 27, 2024

Manufacturing of semi-plastic pharmaceutical dosage units

Inventors: Dominique Kluger (Klosterneuburg, AT); Albin Hauler (Traiskirchen, AT); Carsten Schmidt (Mainz, DE); David Schroeckenfuchs (Ernstbrunn, AT); Niki Waldron (Vallejo, CA)
Assignee: Intervet Inc.
A61K9/0056A61K31/42A61K47/10B29C43/003B29K2071/02B29K2105/0035B29L2031/753
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,911,503
App. No.
17/225,634
Granted
Feb 27, 2024
Kind
B2
Abstract

A process for the manufacture of semi-plastic pharmaceutical unit doses using a rotary moulding machine and semi-plastic pharmaceutical dosage units obtained by this process.

Claims (14)

1. A soft chewable veterinary pharmaceutical product for oral administration,

wherein the soft chewable veterinary pharmaceutical product is obtainable by a process wherein the soft chewable veterinary pharmaceutical product is formed with a rotary moulding machine, comprising the steps of:

a) mixing at least one active pharmaceutical ingredient with one or more components wherein the components are dry components and liquid components to prepare a premix,

b) heating a polyethylene glycol forming agent until melting,

c) mixing the premix and the polyethylene glycol forming agent together to form a dough,

d) feeding the dough into a container connected with a rotary moulding machine; and

e) forming a soft chewable veterinary pharmaceutical product for oral administration in a rotary moulding machine,

wherein the liquid component comprises one or more oils and the polyethylene glycol forming agent is solid at room temperature and has a melting point between 45° C. and 100° C.;

wherein the temperature of the dough in step d) is between 35° C. and 45° C.; and

wherein the rotary moulding machine does not have a knockoff mechanism or a punch mechanism;

wherein the active pharmaceutical ingredient is 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide; and

wherein the soft chewable veterinary pharmaceutical product has concave edges and has a weight of about 2 g or less or has a weight of more than about 10 g.

2. The soft chewable veterinary pharmaceutical product for oral administration according to claim 1 , wherein soft chewable veterinary pharmaceutical product is of cylindrical form.

3. A method of controlling a parasitic insect, acarid or nematode infestation of an animal comprising administering to the animal an effective amount of the soft chewable veterinary pharmaceutical product for oral administration of claim 1 .

Assignments (2)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2021
From: KLUGER, DOMINIQUE; HAULER, ALBIN; SCHMIDT, CARSTEN; SCHROECKENFUCHS, DAVID; WALDRON, NIKI
To: INTERVET INC.
Reel/Frame 055867/0510 →
Continuity (7)
Continuation 16515762 · Jul 18, 2019
Continuation 15988325 · May 24, 2018
Continuation 15359917 · Nov 23, 2016
Continuation 14082813 · Nov 18, 2013
Provisional Application 61791385 · Mar 15, 2013
Provisional Application 61728379 · Nov 20, 2012
Related Publication 20210236420A1 · Aug 5, 2021